Ritonavir-boosted atazanavir-based regimens are better than lopinavir-based regimens for HIV patients in high-income countries, according to a new study from Europe and the United States.
Ritonavir-boosted atazanavir-based regimens are better than lopinavir-based regimens for HIV patients in high-income countries, according to a new study from Europe and the United States.
According to a new study published in the New England Journal of Medicine, patients with HIV covered by Medicaid who had medical comorbidities and behavioral health disorders had fewer inpatient services, more outpatient services, and overall...
According to a new study published in the New England Journal of Medicine, patients with HIV covered by Medicaid who had medical comorbidities and behavioral health disorders had fewer inpatient services, more outpatient services, and overall...
Although the growing number of people living with cancer and the introduction of new therapies are associated with an increase in cancer care costs, a new report from Milliman Inc, commissioned by the Community Oncology Alliance, sheds light...
Although the growing number of people living with cancer and the introduction of new therapies are associated with an increase in cancer care costs, a new report from Milliman Inc, commissioned by the Community Oncology Alliance, sheds light...
US demand for healthcare services seems low heading into 2015, lending weight to the thesis that an improving economy will not lead healthcare spending to skyrocket.
US demand for healthcare services seems low heading into 2015, lending weight to the thesis that an improving economy will not lead healthcare spending to skyrocket.
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Ferdinand Formoso, DO, discusses the role of condoliase as a minimally invasive treatment for lumbar disc herniation, its safety profile, potential areas for further research, and its ability to address unmet needs in spine...
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael Kolodziej, MD, discusses strategies for enhancing biosimilar adoption in the US, emphasizing lessons from global markets, the importance of payer flexibility, and the need for collaboration to reduce costs and...
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
In this interview, Michael Kolodziej, MD, discusses the role of biosimilars in value-based care models, their relationship with targeted therapies, and the impact of policy changes and market trends on biosimilar adoption and cost...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
John Hennessy, MBA, discusses the complexities of biosimilar adoption, highlighting potential cost savings, payer strategies, challenges in provider and patient acceptance, regulatory impacts, and the critical need for sustainable market...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...